VVOS Vivos Therapeutics, Inc.: institutional ownership and insider trading
24 funds reported holding $832K of Vivos Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $449K, with 3 new positions and 4 funds selling out; over the last 12 months insiders bought $1.81M and sold $0 on the open market.
Largest institutional holders of VVOS
- VANGUARD GROUP INC — $617K
- GEODE CAPITAL MANAGEMENT, LLC — $38.6K
- IHT Wealth Management, LLC — $34.9K
- VANGUARD CAPITAL MANAGEMENT LLC — $27.6K
- COMMONWEALTH EQUITY SERVICES, LLC — $19.3K
- UBS Group AG (UBS) — $17.8K
- BlackRock, Inc. (BLK) — $12.6K
- STATE STREET CORP (STT, STT-PG) — $11.3K
- Sequoia Financial Advisors, LLC — $10.9K
- VANGUARD FIDUCIARY TRUST CO — $10.7K
Recent VVOS insider trades
- Mar 31, 2026: Skaff Michael C bought 1,353,625 shares ($1.81M)
5%+ owners
- SP Manager LLC: 19.9% (Schedule 13D, filed Jul 15, 2026)